Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 error replacing the study record. Key study documents and navigation to the trial details appear removed or hidden.SummaryDifference18%

- Check9 days agoChange DetectedThe Related topics section no longer lists 'Multiple myeloma' or the 'MedlinePlus Genetics' resource. The 'related topics' heading has also been removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a note indicating NIH funding (2018 U.S. NIH Grant/Contract) and updated the study record revision to v3.6.6, replacing v3.6.5.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page adds related topic links for Multiple myeloma and MedlinePlus Genetics to connect users with genetics information relevant to the disease.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's content no longer includes the term 'Multiple myeloma' in the conditions and related topics sections and removes the 'MedlinePlus Genetics' reference. This changes how the study is described and how related educational resources are linked.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now includes a 'Multiple myeloma' topic tag and expands the related topics to include 'MedlinePlus Genetics'. The revision stamp was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.